Nuvectis Pharma, Inc.
Institutional Ownership & Holdings Analysis
About
nuvectis-pharma is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | VANGUARD GROUP INC(2025-03-31) | $4.6M |
2 | BALDWIN WEALTH PARTNERS LLC/MA(2025-03-31) | $3.5M |
3 | IRIDIAN ASSET MANAGEMENT LLC/CT(2025-03-31) | $2.5M |
4 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $1.3M |
5 | MILLENNIUM MANAGEMENT LLC(2025-03-31) | $1.2M |
6 | UBS Group AG(2025-03-31) | $1.1M |
7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP(2025-03-31) | $712.2K |
8 | BlackRock, Inc.(2025-03-31) | $669.1K |
9 | FORBES J M & CO LLP(2025-03-31) | $576.4K |
10 | GOLDMAN SACHS GROUP INC(2025-03-31) | $445.6K |
11 | Austin Wealth Management, LLC(2025-03-31) | $441.1K |
12 | JANE STREET GROUP, LLC(2025-03-31) | $413.3K |
13 | OPPENHEIMER & CO INC(2025-03-31) | $400.6K |
14 | MARSHALL WACE, LLP(2025-03-31) | $379.8K |
15 | NORTHERN TRUST CORP(2025-03-31) | $371.8K |
16 | GSA CAPITAL PARTNERS LLP(2025-03-31) | $340.0K |
17 | OMERS ADMINISTRATION Corp(2025-03-31) | $321.3K |
18 | STATE STREET CORP(2025-03-31) | $271.1K |
19 | TWO SIGMA INVESTMENTS, LP(2025-03-31) | $196.3K |
20 | Qube Research & Technologies Ltd(2024-12-31) | $165.5K |
As of 2025-03-31
Value:$4.6M
As of 2025-03-31
Value:$3.5M
As of 2025-03-31
Value:$2.5M
As of 2025-03-31
Value:$1.3M
As of 2025-03-31
Value:$1.2M
As of 2025-03-31
Value:$1.1M
As of 2025-03-31
Value:$712.2K
As of 2025-03-31
Value:$669.1K
As of 2025-03-31
Value:$576.4K
As of 2025-03-31
Value:$445.6K
As of 2025-03-31
Value:$441.1K
As of 2025-03-31
Value:$413.3K
As of 2025-03-31
Value:$400.6K
As of 2025-03-31
Value:$379.8K
As of 2025-03-31
Value:$371.8K
As of 2025-03-31
Value:$340.0K
As of 2025-03-31
Value:$321.3K
As of 2025-03-31
Value:$271.1K
As of 2025-03-31
Value:$196.3K
As of 2024-12-31
Value:$165.5K
Total Institutional Holders:42
Top 10 Holders Own:78.8%